Seed Investment

CanCertain (formerly CLYZ Labs) is developing a testing service to select the best drug therapy for personalised cancer treatment. CanCertain will combine information on the sensitivity of the patients own tumor cells to a range of drugs along with biomarker and treatment guidelines to provide a personalised treatment recommendation. This is expected to increase life expectancy and reduce costs by selecting the best treatment option for an individual.

Highly personalised cancer therapy is fast becoming the standard of care and CanCertain is well positioned to provide an fully integrated service to support clinicians to provide the best treatment and care for patients.


Our Approach

What do we look for?

Our business is about forming long term relationships with exceptional entrepreneurs and becoming a trusted partner and supportive investor.

We look for companies with both the vision and potential to become ‘game changers’ and market leaders across a range of sectors.

learn more

Our Team

Rob Carroll

view complete team

Contact us

Binder House
7 Narborough Wood Park
Desford Road
LE19 4XT

Tel: 0116 238 8200